Share this post on:

Name :
JAK2 antibody

Documents :
DataSheet Material Safety Data Sheets (MSDS)

Description :
JAK2 Rabbit Polyclonal antibody. Positive WB detected in Jurkat cells. Positive IP detected in Jurkat cells. Observed molecular weight by Western-blot: 150 kDa

Tested applications :
ELISA, WB, IP

Species reactivity :
Human,Mouse,Rat; other species not tested.

Alternative names :
JAK 2 antibody; JAK2 antibody; Janus kinase 2 antibody; JTK10 antibody; Tyrosine protein kinase JAK2 antibody

Immunogen :

Isotype :
Rabbit IgG

Preparation :
This antibody was obtained by immunization of JAK2 recombinant protein (Accession Number: NM_001322195). Purification method: Antigen affinity purified.

Clonality :
Polyclonal

Formulation :
PBS with 0.1% sodium azide and 50% glycerol pH 7.3.

Storage instructions :
Store at -20℃. DO NOT ALIQUOT

Applications :
Recommended Dilution: WB: 1:200-1:2000IP: 1:200-1:1000

Background :
JAK2 represents Janus kinase 2 (a protein tyrosine kinase)

References :

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
MSR1 Antibody
PDK1 Antibody
CD38 Antibody: CD38 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to CD38. It can be used for WB,IHC-P,ICC assays with tag free, in the background of Human.

Share this post on:

Author: Gardos- Channel